Loading...
By Christine Judge
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Use of beta-blockers is not associated with increased risk for depression, researchers report in Hypertension.
The finding comes from a systematic review in which investigators examined risks for psychiatric adverse events in 285 double-blind, randomized, controlled trials of beta-blockers comprising more than 50,000 patients. Most trials were in patients with cardiovascular disease and were conducted over 20 years ago.
While depression was the most common psychiatric adverse event reported, in a meta-analysis, beta-blocker use was not associated with higher likelihood of depression or withdrawal of therapy due to depression, compared with placebo or active comparator drugs.
The authors conclude that long-standing concerns about psychiatric adverse events related to beta-blockers are "mostly unwarranted" and "should not affect their use in clinical practice." They also note secondary findings of possible increased risk for sleep-related disorders that merit further study.
Comment
LINK(S):
Hypertension article (Free abstract)
Background: NEJM Journal Watch coverage of beta-blockers and psychopathology (Your NEJM Journal Watch subscription required)